Compare WATR & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WATR | CLNN |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.7M | 57.4M |
| IPO Year | 2026 | 2021 |
| Metric | WATR | CLNN |
|---|---|---|
| Price | $1.23 | $3.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.20 |
| AVG Volume (30 Days) | 31.5K | ★ 81.0K |
| Earning Date | N/A | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $200,000.00 |
| Revenue This Year | $199.86 | $24.70 |
| Revenue Next Year | $1,070.73 | $9,228.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.21 | $3.02 |
| 52 Week High | $2.53 | $11.59 |
| Indicator | WATR | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 27.18 | 44.48 |
| Support Level | N/A | $3.13 |
| Resistance Level | $2.04 | $4.70 |
| Average True Range (ATR) | 0.17 | 0.28 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 4.82 | 63.07 |
Air Water Ventures Ltd is a sustainable water solutions provider that produces drinking water by extracting humidity from the air. Its business includes premium packaged water sold in cans and bottles, manufacturing atmospheric water generators (AWGs) ranging from consumer to industrial scale, and operating water production and bottling facilities. The company has two reportable segments: bottling revenue and other revenue. Bottling revenue includes sales of packaged water, installation of bottling units at customer or own facilities, and supply of water via air-to-water generators to hospitality customers. Other revenue, the key revenue segment, includes sales of air-to-water generator machines, related maintenance and after-sales services, and leasing of air-to-water generator units.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.